Translocation capture sequencing: a method for high throughput mapping of chromosomal rearrangements.

TitleTranslocation capture sequencing: a method for high throughput mapping of chromosomal rearrangements.
Publication TypeJournal Article
Year of Publication2012
AuthorsOliveira TY, Resch W, Jankovic M, Casellas R, Nussenzweig MC, Klein IA
JournalJ Immunol Methods
Volume375
Issue1-2
Pagination176-81
Date Published2012 Jan 31
ISSN1872-7905
KeywordsAnimals, B-Lymphocytes, Chromosome Mapping, Cytidine Deaminase, DNA Breaks, Double-Stranded, DNA Damage, Genes, myc, Genome-Wide Association Study, Immunoglobulin Heavy Chains, Lymphoma, B-Cell, Mice, Sequence Analysis, DNA, Translocation, Genetic
Abstract

Chromosomal translocations require formation and joining of DNA double strand breaks (DSBs). These events disrupt the integrity of the genome and are involved in producing leukemias, lymphomas and sarcomas. Translocations are frequent, clonal and recurrent in mature B cell lymphomas, which bear a particularly high DNA damage burden by virtue of activation-induced cytidine deaminase (AID) expression. Despite the ubiquity of genomic rearrangements, the forces that underlie their genesis are not well understood. Here, we provide a detailed description of a new method for studying these events, translocation capture sequencing (TC-Seq). TC-Seq provides the means to document chromosomal rearrangements genome-wide in primary cells, and to discover recombination hotspots. Demonstrating its effectiveness, we successfully estimate the frequency of c-myc/IgH translocations in primary B cells, and identify hotspots of AID-mediated recombination. Furthermore, TC-Seq can be adapted to generate genome-wide rearrangement maps in any cell type and under any condition.

DOI10.1016/j.jim.2011.10.007
Alternate JournalJ. Immunol. Methods
PubMed ID22033343
PubMed Central IDPMC3285106
Grant ListR01 AI037526 / AI / NIAID NIH HHS / United States
GM07739 / GM / NIGMS NIH HHS / United States
/ / Intramural NIH HHS / United States
R01 AI037526-17 / AI / NIAID NIH HHS / United States
/ / Howard Hughes Medical Institute / United States
AI037526 / AI / NIAID NIH HHS / United States
R37 AI037526 / AI / NIAID NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States

Person Type: